If you need more lookups,
subscriptions start at $34 USD/month.
John Greulich Location
United States
John Greulich Work
Executive Director, Access and Reimbursement - Neuromuscular and Oncology @ (February 2026 - Present)
Director, Access and Reimbursement @ (September 2019 - February 2026)
Director, Reimbursement, Market Access and Pricing @ (June 2013 - September 2019)
Director, Channel Access @ (April 2012 - June 2013)
Assoc. Director - Site of Care @ (September 2009 - April 2012)
District Sales Manager @ (April 2008 - September 2009)
Immunology Sales Specialist @ (October 2006 - April 2008)
Manager, Training @ (January 2005 - January 2006)
Senior Territory Manager @ (January 2004 - January 2005)
Territory Manager @ (January 2001 - January 2004)
John Greulich Education
Shippensburg University of Pennsylvania
BS
John Greulich Skills
Managed Care
Urology
Gastroenterology
Rheumatology
Oncology
Pharmaceutical Industry
Medical Devices
Hospitals
Biotechnology
Selling Skills
Buy
Immunology
Training
Hospital Sales
Biologics
Surgeons
Pharmaceutical Sales
Neurology
Central Nervous System
Medicare
Injectable
Managed Markets
Cardiology
Real Estate Transactions
Buy & Bill
Endocrinology
Sales Force Development
Product Launch
Allergy
OB/GYN
Dermatology
Sales Effectiveness
Pharmacy
Osteoporosis
Diabetes
Nephrology
Pharmaceutics
Market Access
Healthcare
Cross-functional Team Leadership
Sales
Management
Leadership
Buy
Buy and Bill
Cross Functional Team Leadership
John Greulich Summary
John Greulich, based in United States, is currently a Executive Director, Access and Reimbursement - Neuromuscular and Oncology at Novartis. John Greulich brings experience from previous roles at Novartis Oncology and UCB. John Greulich holds a BS @ Shippensburg University of Pennsylvania. With a robust skill set that includes Managed Care, Urology, Gastroenterology, Rheumatology, Oncology and more. John Greulich has 6 emails and 4 mobile phone numbers on RocketReach.
Looking for a different John Greulich?
Find contact details for 700 million professionals.